Cannara Biotech Inc. (TSXV:LOVE)
Canada
· Delayed Price · Currency is CAD 1.330
+0.010 (0.76%)
May 12, 2025, 3:59 PM EDT
Cannara Biotech Revenue
Cannara Biotech had revenue of 26.46M CAD in the quarter ending February 28, 2025, with 34.57% growth. This brings the company's revenue in the last twelve months to 94.07M, up 28.41% year-over-year. In the fiscal year ending August 31, 2024, Cannara Biotech had annual revenue of 81.75M with 42.77% growth.
Revenue (ttm)
94.07M
Revenue Growth
+28.41%
P/S Ratio
1.29
Revenue / Employee
n/a
Employees
n/a
Market Cap
121.61M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.55B |
| Sienna Senior Living | 896.45M |
| Extendicare | 1.47B |
| Trulieve Cannabis | 1.71B |
| Cronos Group | 179.08M |
| WELL Health Technologies | 919.69M |
| Curaleaf Holdings | 1.89B |